Product Code: 47990
KEY FINDINGS
The global medical electrodes market is forecasted to rise with a CAGR of 4.44% across the estimated years 2022 to 2030. The market growth of the region is determined by key factors such as the increase in neurological and cardiovascular diseases, rising investments in the healthcare sector, and the growing preference for home and ambulatory healthcare services.
MARKET INSIGHTS
Medical electrodes transfer the energy of ionic currents in the body into electrical currents, which are studied, amplified, and used to make diagnoses. They also offer contact between the patient as well as the device used to measure or record cardiac and neurological activity.
As a result, medical electrodes are utilized for the diagnosis of numerous cardiac, ocular, nervous, and muscular diseases. Various electrodes are used in the diagnosis of different conditions. For instance, ECG electrodes examine heart rate, EMG electrodes measure muscular response, EEG electrodes identify brain wave patterns, and electrosurgical electrodes help perform minimally invasive surgical processes through the use of radiofrequency alternating current. In addition, various other electrodes are utilized for the identification of cardiological and neurological diseases.
REGIONAL INSIGHTS
The global medical electrodes market growth analysis constitutes the evaluation of North America, Asia-Pacific, Europe, and Rest of World. The Asia-Pacific is expected to grow with the highest CAGR during the forecasted years. The growing risk of diseases associated with the surging geriatric population, in addition to the increasing preference for home and ambulatory health care services, are among the primary factors accredited to the market growth of the region.
COMPETITIVE INSIGHTS
The competition in the global medical electrodes market is very strong owing to the low product differentiation among key players, such as 3M Company, Zoll Medical Corporation, Dymedix Diagnostics, Cooper Surgical, and others.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
- 1.1. STUDY OBJECTIVES
- 1.2. SCOPE OF STUDY
- 1.3. METHODOLOGY
- 1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
- 2.1. MARKET SIZE & ESTIMATES
- 2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
- 3.1. KEY DRIVERS
- 3.1.1. INCREASING NUMBER OF NEUROLOGICAL AND CARDIOVASCULAR DISEASES
- 3.1.2. RISING INVESTMENTS IN HEALTHCARE SECTOR
- 3.1.3. GROWING PREFERENCE FOR HOME AND AMBULATORY HEALTHCARE SERVICES
- 3.2. KEY RESTRAINTS
- 3.2.1. GOVERNMENT REGULATIONS
- 3.2.2. TIME-CONSUMING BIO-COMPATIBILITY TESTING
4. KEY ANALYTICS
- 4.1. IMPACT OF COVID-19 ON MEDICAL ELECTRODES MARKET
- 4.2. KEY MARKET TRENDS
- 4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
- 4.4. OPPORTUNITY MATRIX
- 4.5. VENDOR LANDSCAPE
- 4.6. VALUE CHAIN ANALYSIS
- 4.6.1. MANUFACTURING
- 4.6.2. TECHNOLOGY INTEGRATION
- 4.6.3. DISTRIBUTORS/SUPPLIERS
- 4.6.4. END-USER
- 4.7. REGULATORY FRAMEWORK
5. MARKET BY TYPE
- 5.1. DIAGNOSTICS MEDICAL ELECTRODES
- 5.1.1. ELECTROCARDIOGRAM (ECG)
- 5.1.2. ELECTROENCEPHALOGRAM (EEG)
- 5.1.3. ELECTROMYOGRAM (EMG)
- 5.1.4. ELECTRORETINOGRAM (ERG)
- 5.1.5. FETAL SCALP
- 5.1.6. OTHER DIAGNOSTICS
- 5.2. THERAPEUTIC MEDICAL ELECTRODES
- 5.2.1. PACEMAKERS
- 5.2.2. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS (TENS)
- 5.2.3. DEFIBRILLATORS
- 5.2.4. ELECTROSURGICAL ELECTRODES
- 5.2.5. OTHER THERAPEUTICS
6. MARKET BY PRODUCT
- 6.1. SURFACE ELECTRODES
- 6.2. NEEDLE ELECTRODES
7. MARKET BY USABILITY
- 7.1. DISPOSABLE MEDICAL ELECTRODES
- 7.2. REUSABLE MEDICAL ELECTRODES
8. MARKET BY APPLICATION
- 8.1. CARDIOLOGY
- 8.2. INTRAOPERATIVE MONITORING (IOM)
- 8.3. NEUROPHYSIOLOGY
- 8.4. SLEEP DISORDERS
- 8.5. OTHER APPLICATIONS
9. GEOGRAPHICAL ANALYSIS
- 9.1. NORTH AMERICA
- 9.1.1. MARKET SIZE & ESTIMATES
- 9.1.2. KEY GROWTH ENABLERS
- 9.1.3. KEY CHALLENGES
- 9.1.4. KEY PLAYERS
- 9.1.5. COUNTRY ANALYSIS
- 9.1.5.1. UNITED STATES
- 9.1.5.2. CANADA
- 9.2. EUROPE
- 9.2.1. KEY GROWTH ENABLERS
- 9.2.2. KEY CHALLENGES
- 9.2.3. KEY PLAYERS
- 9.2.4. COUNTRY ANALYSIS
- 9.2.4.1. UNITED KINGDOM
- 9.2.4.2. GERMANY
- 9.2.4.3. FRANCE
- 9.2.4.4. ITALY
- 9.2.4.5. SPAIN
- 9.2.4.6. NORDIC COUNTRIES
- 9.2.4.7. REST OF EUROPE
- 9.3. ASIA-PACIFIC
- 9.3.1. KEY GROWTH ENABLERS
- 9.3.2. KEY CHALLENGES
- 9.3.3. KEY PLAYERS
- 9.3.4. COUNTRY ANALYSIS
- 9.3.4.1. CHINA
- 9.3.4.2. JAPAN
- 9.3.4.3. INDIA
- 9.3.4.4. SOUTH KOREA
- 9.3.4.5. INDONESIA
- 9.3.4.6. TAIWAN
- 9.3.4.7. SINGAPORE
- 9.3.4.8. AUSTRALIA & NEW ZEALAND
- 9.3.4.9. REST OF ASIA-PACIFIC
- 9.4. REST OF WORLD
- 9.4.1. KEY GROWTH ENABLERS
- 9.4.2. KEY CHALLENGES
- 9.4.3. KEY PLAYERS
- 9.4.4. REGIONAL ANALYSIS
- 9.4.4.1. LATIN AMERICA
- 9.4.4.2. MIDDLE EAST & AFRICA
10. COMPETITIVE LANDSCAPE
- 10.1. KEY STRATEGIC DEVELOPMENTS
- 10.1.1. MERGERS & ACQUISITIONS
- 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 10.1.3. PARTNERSHIPS & AGREEMENTS
- 10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
- 10.2. COMPANY PROFILES
- 10.2.1. 3M
- 10.2.2. AMBU A/S
- 10.2.3. CARDINAL HEALTH
- 10.2.4. COGNIONICS INC
- 10.2.5. CONMED CORPORATION
- 10.2.6. COOPER SURGICAL
- 10.2.7. CR BARD
- 10.2.8. DYMEDIX DIAGNOSTICS
- 10.2.9. KONINKLIJKE PHILIPS NV
- 10.2.10. MEDICO ELECTRODES
- 10.2.11. MEDTRONIC PLC
- 10.2.12. NATUS MEDICAL INCORPORATED
- 10.2.13. PEPIN MANUFACTURING INC
- 10.2.14. RHYTHMLINK INTERNATIONAL
- 10.2.15. ZOLL MEDICAL CORPORATION